Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I/II Trial of EMD 121974 for Treatment of Patients With Recurrent Anaplastic Gliomas

NCT00006093 is registered in ClinicalTrials.gov with New Approaches to Brain Tumor Therapy Consortium as lead sponsor.

NCT NCT00006093
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00006093 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I/II Trial of EMD 121974 for Treatment of Patients With Recurrent Anaplastic Gliomas
Lead sponsor
New Approaches to Brain Tumor Therapy Consortium
Phase
Phase 1/2
Overall status
Completed
Start date
September 30, 2000
Completion date
October 31, 2006
Enrollment
Not reported
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

brain and central nervous system tumors